![Public Health Review Morning Edition artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts115/v4/66/23/d0/6623d0c0-1eef-ee5c-55a8-0f88dda85236/mza_441932648873605984.png/100x100bb.jpg)
500: Xylazine Plan, Diverse Executives Address Equity
Public Health Review Morning Edition
English - September 11, 2023 09:00 - 5 minutes - 7.25 MB - ★★★★★ - 44 ratingsMedicine Health & Fitness Government healthcare health healthnews news publichealth Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 499: Equity Strategies Cohort Forming, Federal Shutdown Looms
Dr. Rahul Gupta, Director of National Drug Control Policy at the White House, outlines the federal government’s response to the threat of Xylazine; the 2024 Diverse Executives Leading in Public Health (DELPH) Program is accepting applications for professional development; a new ASTHO blog article explains how data modernization intersects with diversity, equity, and inclusion; and the Morning Edition celebrates its 500th episode.
ASTHO Webpage: Public Health Officials Stand Ready to Implement White House Xylazine Response Plan
ASTHO Webpage: Diverse Executives Leading in Public Health Application
ASTHO Webpage: The Search for Good Data to Support Health Equity in Public Health